Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0 Study of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers

NCT07774650 is registered in ClinicalTrials.gov with Ratio Therapeutics, Inc. as lead sponsor.

NCT NCT07774650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07774650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0 Study of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers
Lead sponsor
Ratio Therapeutics, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
July 8, 2026
Completion date
December 31, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer